ActRIIA-IgG1Fc

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	33

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 10 of 33 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005061-13-AT (EUCTR)	05/05/2022	02/12/2021	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011/ MK-7962 INN or Proposed INN: SOTATERCEPT ...	Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ, USA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	Serbia;Portugal;United States;Taiwan;Greece;Spain;Israel;Colombia;Switzerland;Italy;France;Australia ...
2	EUCTR2020-005061-13-HR (EUCTR)	14/04/2022	12/05/2022	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011 INN or Proposed INN: SOTATERCEPT Other des ...	Acceleron Pharma Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	Serbia;Portugal;United States;Taiwan;Greece;Spain;Israel;Colombia;Italy;Switzerland;France;Australia ...
3	EUCTR2020-005061-13-DK (EUCTR)	25/03/2022	22/12/2021	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011 INN or Proposed INN: SOTATERCEPT Other des ...	Acceleron Pharma Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	Serbia;Portugal;United States;Taiwan;Greece;Spain;Israel;Colombia;Switzerland;Italy;France;Australia ...
4	EUCTR2020-005061-13-PT (EUCTR)	18/03/2022	07/12/2021	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011 INN or Proposed INN: SOTATERCEPT Other des ...	Acceleron Pharma Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	Germany;New Zealand;Sweden;United States;Serbia;Portugal;Taiwan;Greece;Spain;Israel;Colombia;Italy;S ...
5	EUCTR2020-005061-13-BE (EUCTR)	07/03/2022	26/11/2021	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011 / MK-7962 INN or Proposed INN: SOTATERCEP ...	Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ, USA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	Serbia;Portugal;United States;Taiwan;Greece;Israel;Colombia;Switzerland;Italy;France;Australia;Denma ...
6	EUCTR2020-005061-13-CZ (EUCTR)	02/03/2022	20/12/2021	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011 / MK - 7962 INN or Proposed INN: SOTATERC ...	Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ, USA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	Serbia;Portugal;United States;Taiwan;Greece;Spain;Israel;Colombia;Switzerland;Italy;France;Denmark;A ...
7	EUCTR2020-005061-13-NL (EUCTR)	09/02/2022	25/11/2021	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011 INN or Proposed INN: SOTATERCEPT Other des ...	Acceleron Pharma Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	United States;Serbia;Portugal;Taiwan;Greece;Spain;Ireland;Israel;Colombia;Switzerland;Italy;France;A ...
8	EUCTR2021-001498-21-DE (EUCTR)	01/02/2022	24/09/2021	A study to evaluate Sotatercept in Participants with PAH WHO FC III or FC IV at High Risk of Mortali ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sotatercept When Added to ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept Product Code: ACE-011 INN or Proposed INN: SOTATERCEPT Other descriptive name ...	Acceleron Pharma Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	166	Phase 3	France;United States;Mexico;Canada;Spain;Belgium;Australia;Israel;Netherlands;Germany;United Kingdom ...
9	EUCTR2020-005061-13-PL (EUCTR)	26/01/2022	02/12/2021	A Long-term Follow-up Study of Sotatercept for PAH Treatment	An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Backgro ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept - 60 mg/vial Product Code: ACE-011/ MK-7962 INN or Proposed INN: SOTATERCEPT ...	Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ, USA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	700	Phase 3	United States;Czechia;Portugal;Greece;Austria;Sweden;Netherlands;Poland;Brazil;Korea, Republic of;Fr ...
10	EUCTR2021-000199-12-IT (EUCTR)	26/01/2022	09/09/2021	A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- andHigh-risk Pulmonary arterial hype ...	A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10064911;Te ...	Product Name: Sotatercept Product Code: [ACE-011] INN or Proposed INN: SOTATERCEPT Other descriptive na ...	ACCELERON PHARMA INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	662	Phase 3	Serbia;United States;Portugal;Taiwan;Greece;Spain;Ireland;Israel;Chile;Colombia;Switzerland;Italy;Fr ...

First Previous1 2 3 4Next Last